Array Biopharma Inc $3.65

down -0.11


22/9/2014 04:00 PM  |  NASDAQ : ARRY  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ARRY Trend Analysis - it has underperformed the S&P 500 by 59%

Partner Headlines

  1. Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer

    Benzinga
  2. Earnings Scheduled For August 12, 2014

    Benzinga
  3. Pepsi Beats; Positive Phase 3 Breast Cancer Data Creates Potential Buyout ...

    Benzinga
  4. Intuitive Surgical Rises On Upbeat Earnings; Xilinx Shares Slip

    Benzinga
  5. Markets Mixed; PepsiCo Q2 Earnings Beat Street View

    Benzinga
  6. Events Scheduled for Week of Jun. 16th to Jun. 20th

    Benzinga
  7. Array Biopharma Announces Binimetinib Continues to Advance in Clinical ...

    Benzinga
  8. Benzinga's Top #PreMarket Losers

    Benzinga
  9. Morning Gainers for Mar. 3, 2014: DNDN, PERI, RVNC, ARRY, OMEX, NIHD

    Benzinga
  10. Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ...

    Benzinga
  11. Array BioPharma Issues Update on ARRY-614 for Myelodysplastic Syndromes ...

    Benzinga
  12. Array BioPharma Issues Update on ARRY-520 for Multiple Myeloma at '13 ASHM

    Benzinga
  13. Pharmaceutical Industry Expected To Collect Billions From Obamacare

    Benzinga
  14. These ETFs House The Next Biotech Takeover Targets

    Benzinga
  15. Benzinga's Top Pre-Market Losers

    Benzinga
  16. Array BioPharma Provides Updates On Clinical Data At The 2012 American ...

    Benzinga
  17. John Orwin Joins Array BioPharma Board Of Directors

    Benzinga
  18. Array BioPharma Inc. Reports Operating Results (10-Q)

    GuruFocus
  19. Array BioPharma CEO Favors Open, Unbiased Questions

    IBD
  20. Singles Only: 3 Low-Priced Stocks for Your Portfolio

    SchaeffersResearch
  21. Array Announces Changes to Board

    Benzinga
  22. Array BioPharma Inc. Reports Operating Results (10-K)

    GuruFocus
  23. Polypore International, True Religion Apparel Among Stocks Gapping Down ...

    FoxBusiness
  24. Health Care Sector Wrap

    FoxBusiness
  25. Array BioPharma Achieves $8.5 Million Clinical Milestone in Amgen Diabetes ...

    Benzinga
  26. Clovis Oncology and Array BioPharma Announce Agreement to Discover Novel ...

    Benzinga
  27. MEK162 Shows Promising Clinical Activity in Ongoing Phase 2 Trial

    Benzinga
  28. Highs & Lows: Array BioPharma, NII Holdings, and MEMC Electronic Materials

    SchaeffersResearch
  29. Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,545 Shares

    GuruFocus
  30. Array BioPharma Announces Proposed Public Offering of 20M Shares

    Benzinga
  31. Benzinga's Top Pre-Market Losers

    Benzinga
  32. Array BioPharma Inc. Reports Operating Results (10-Q)

    GuruFocus
  33. Array BioPharma Names Gwen A. Fyfe, M.D. to Board of Directors

    Benzinga
  34. From Earlier: Array BioPharma's Chief Executive Officer Robert E. Conway ...

    Benzinga
  35. Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,994 Shares

    GuruFocus
  36. Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,743 Shares

    GuruFocus
Trading Center